Rankings
▼
Calendar
MESO Q2 2023 Earnings — Mesoblast Limited Revenue & Financial Results | Market Cap Arena
MESO
Mesoblast Limited
$2B
Q2 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$2M
-16.9% YoY
Gross Profit
-$14M
-686.7% margin
Operating Income
-$21M
-1066.3% margin
Net Income
-$24M
-1236.7% margin
EPS (Diluted)
$-0.32
QoQ Revenue Growth
+37.2%
Cash Flow
Operating Cash Flow
-$16M
Free Cash Flow
-$16M
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$668M
Total Liabilities
$168M
Stockholders' Equity
$500M
Cash & Equivalents
$67M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$2M
$2M
-16.9%
Gross Profit
-$14M
-$14M
+5.6%
Operating Income
-$21M
-$22M
+5.0%
Net Income
-$24M
-$26M
+5.6%
← FY 2023
All Quarters
Q3 2023 →